United States

People: GenVec Inc (GNVC.OQ)

GNVC.OQ on NASDAQ Stock Exchange Capital Market

17 Feb 2017
Change (% chg)

$-0.10 (-1.40%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Brough, Douglas 

Dr. Douglas E. Brough, Ph.D., is Chief Scientific Officer since September 2013. Dr. Brough previously held several positions at GenVec including Senior Vice President, Research, Vice President, Head of Research, Executive Director of Vector Sciences, Senior Director of Vector Sciences, Director of Vector Sciences, Director of Molecular Virology, Head Molecular Virology and Research Scientist. Prior to joining GenVec, Dr. Brough was a Research Fellow in the Department of Molecular Biology at the Lewis Thomas Laboratory, Princeton University. Dr. Brough received his B.S. in Biology from Purdue University, a M.S. in Microbiology and Biochemistry from Idaho State University and his Ph.D. in Microbiology and Molecular Genetics from Rutgers, the State University of New Jersey and the Robert Wood Johnson Medical School. Dr. Brough performed post-doctoral research in molecular biology at Princeton University.

Basic Compensation

Total Annual Compensation, USD 310,650
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 236,766
Fiscal Year Total, USD 547,416

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --